XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
12 Months Ended
Sep. 30, 2022
Jan. 03, 2023
Mar. 31, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Sep. 30, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --09-30    
Entity File Number 333-170315    
Entity Registrant Name GlobeStar Therapeutics Corporation    
Entity Central Index Key 0001502152    
Entity Tax Identification Number 27-3480481    
Entity Incorporation, State or Country Code WY    
Entity Address, Address Line One 719 Jadwin Avenue    
Entity Address, City or Town Richland    
Entity Address, State or Province WA    
Entity Address, Postal Zip Code 99352    
City Area Code 206    
Local Phone Number 451-1970    
Title of 12(b) Security Common stock, $0.001 par value    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 3,963,984
Entity Common Stock, Shares Outstanding   770,360,616  
Auditor Firm ID 2738    
Auditor Name M&K CPAS, PLLC    
Auditor Location Houston, Texas